Completion of the human genome sequencing was announced in 2003 and vast sources of information on genes are now easily accessible. With the benefit of genome studies, it is now widely realized that even a minute alteration in DNA such as a point mutation may cause a disorder in gene expression and become a major cause of disease. Therefore the development of efficient methods for the selective inhibition or modification of a target gene has become a major concern from a therapeutic viewpoint. Sequence-specific inhibition at the translation step has been exhibited based on antisense, ribozyme, siRNA, and miRNA mechanisms. Inhibition at the transcription step is possible by utilizing triple helix-forming oligonucleotides (TFOs), which bind as third strands to duplex DNA to form triplex DNA in a sequencespecific manner. [1] [2] [3] Interesting applications of the triplex DNA include not only inhibition of the target gene, but also induction of point mutations at predetermined sites. As there are a number of reviews of inhibition at the transcription and translation steps, [4] [5] [6] [7] in this mini review we focus on possible applications of triplex DNA for targeted mutagenesis.
Triplex DNA contains the third strand in the major grove of duplex DNA containing homopurine/homopyrimidine stretches, and is stabilized by two Hoogsteen hydrogen bonds between the third strand bases and the purines in the duplex. 8, 9) Triplexes can be formed by third strands consisting of pyrimidines (parallel triplex) or purines (antiparallel triplex), depending on the nature of the target sequences. 10, 11) In the pyrimidine motif, a homopyrimidine oligonucleotide binds in a direction parallel to the purine strand in the duplex with canonical base triplets of T-A:T and C ϩ -G:C.
12) In the alterative purine motif, a homopurine strand binds antiparallel to the purine strand with base triplets of A-A:T and G-G:C (Fig. 1) . 12) We have recently expanded in part the recognition codes of triplex DNA. 13, 14) The binding characteristics and sequence specificity of TFOs give these oligonucleotides vast potential in gene modification, such as inhibition of gene expression, inhibition of replication, and induction of site-specific mutagenesis. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] However, there are a number of obstacles to TFO activity under physiologic conditions. [26] [27] [28] [29] Recent developments in nucleoside and oligonucleotide analogue chemistry show great promise for solving the problems of TFO bioactivity and target options. In particular, TFOs conjugated with reactive molecules can react to the target sequence with specificity and induce mutagenesis around the reactive site. This mini review deals with targeted mutagenesis in vitro and in vivo using modified TFOs, including our own results with the TFOs bearing 2-amino-6-vinylpurine derivatives.
TARGETED MUTAGENESIS BY MODIFIED TFO
Several studies have demonstrated that high-affinity TFOs under physiologic conditions can induce DNA repair and recombination in a manner that can be exploited to introduce desired sequence changes in mammalian cells. Unmodified G-rich oligonucleotides (antiparallel triple helix motif) induced mutations on the supFG1 reporter gene within simian virus 40 vector contained in mammalian cells at frequencies of 0.2%. 30) The sequence analysis of supFG1 mutations found some deletions within and around the triple helix binding site. Point mutations were also detected on that gene in multiple sites with no selectivity. Recently, Vasquez et al. demonstrated that TFOs can induce mutations at specific genome sites in somatic cells of adult mice using transgenic mice. 31) These results show that the formation of triplexes to the target sequence takes place selectively, and site-specific, TFO-directed genome modification can be accomplished in intact animals.
Psoralen forms a photo-adduct with thymine (T) upon UV irradiation. Thus psoralen-linked TFOs were used for photoinductive directed mutagenesis to specific sites in reporter genes (Fig. 2) . Replication/repair of targeted adducts can result in mutagenesis at the target site. 32) In one approach, the target sites were embedded in variant supF genes carried in shuttle vector plasmids that replicate in primate cells. Triplex formation and target modification took place in vitro, followed by introduction of the adducted plasmid into cells. [33] [34] [35] [36] [37] [38] In these experiments, purine-rich TFOs linked to psoralen induced targeted mutations at frequencies in the range of 0.2% to 30% with UV irradiation. Most of the mutations were T · A to A · T transversions precisely at the targeted site of psoralen. Alternatively, the plasmid has been introduced into the cell and some time later the psoralen-TFO transfected. 39) In each protocol, photoactivation of the targeted psoralen produces a cross-link in the duplex (as well as the linkage of the third strand to the target sequence), which during replication or repair of the plasmid results in mutations.
In an attempt to extend TFO targeting strategy to an endogeous chromosomal locus, the hypoxanthine phosphoribosyl transferase gene (HPRT) was used as an endogenous gene, which contained the polypyrimidine-polypurine sequence. Higher binding affinity of TFO to the target genes under physiologic conditions would be essential for bioactivity in this assay system. Various modified pyrimidine motif psoralen-TFOs, designed for the above target, were used for the HPRT knockout assays. TFOs with uniform 2Ј-O-methyl (2Ј-OMe) substitutions, which had stabilized triple helix formation, were inactive, but the addition of a pyrene intercalator conferred knockout activity with HPRT clones recovered at frequencies in the range of 0.01% to 0.1%. 40) More recently, psoralen-TFOs containing several 2Ј-aminoethyl (2Ј-AE) residues as well as 2Ј-OMe substitutions showed the highest HPRT gene knockout activity. 41, 42) The mutagenesis frequencies using psoralen-TFOs with three or four 2Ј-AE residues at terminal positions were 20-30 fold greater than those of the uniformly 2Ј-O-Me-substituted TFOs. These mixed substitution TFOs formed stable triplexes at lower levels of Mg 2ϩ , even at 1 mM Mg 2ϩ concentration, and at physiologic pH in vitro. These results indicate that the introduction of a positive charge can confer the biological activity on the pyrimidine motif of TFOs, and that the biological activity of TFOs is correlated with binding affinity in vitro. These mutagenesis experiments show that the packaging of the DNA into chromatin is not an absolute barrier to gene targeting with TFOs. 43) Successful procedures for the gene manipulation of chromosomal sequences using TFOs will require their high affinity to the target genes under physiologic conditions.
MUTAGENESIS USING TFOS BEARING 2-AMINO-6-VINYLPURINE DERIVATIVES
Although psoralen has been a very useful mutagen as mentioned in the previous section, it has some serious drawbacks. It is sharply restricted in reactivity to pyrimidines, with a strong bias toward thymines, with cross-link formation limited to the 5Ј TA or AT sites. 44, 45) This greatly reduces the target options for gene mutagenesis and knockout applications. Furthermore, it requires photoactivation, and only those TFOs bound at the time of UVA exposure will contribute to the mutagenesis.
Consequently, there is a need for additional compounds that can be linked to TFOs while retaining efficient DNA reactivity. TFOs have been conjugated with haloacetyl amide, 46) aryl nitrogen mustard, 47) aziridine units, 48) or a minor groove-reactive compound 49) and used for interstrand cross-linking of triplex, but the biological consequences following reaction with the DNA target sequences have not been reported. In our approach to selective functional oligonucleotides, we have developed a 2-amino-6-vinylpurine (1) as a cytosine selective cross-linking agent within a duplex. 50, 51) It is notable that the alkylating activity of 1 can be autogenerated within the duplex from its stable precursor, a phenylsulfide or phenylsulfoxide derivative (Fig. 3) .
52) The proximity effect between 1 and cytosine would play a crucial role in these selective reactions. Based on this concept, the new nucleoside derivative (2) was designed for triple helix- forming cross-linking. The derivative (2) has a butyl spacer between the sugar part and the 2-amino-6-vinylupurine motif, and could be proximal to a flipping cytosine in the duplex (Fig. 4) . The TFO bearing 2 has achieved strand-and cytosine-selective cross-linking reactions to the G-C target site. 53, 54) The high selectivity to cytosine in the pyrimidine strand would be due to a complex between the protonated form of the 2-amino-6-vinylpurine moiety and a cytosine which is flipped out from the GC pair. The pinpoint selectivity will be useful for application to site-specific modifications. Thus we have investigated mutations caused by the reactive TFO bearing 2 at the site of cross-linking with the shuttle vector plasmids that replicate in mammalian cells.
The reactive TFOs were designed to form a triplex with the target sequence embedded within supF mutation marker genes carried in shuttle vector plasmids (Fig. 5A) . In our previous study, a TFO containing 2 at the internal position showed selective reaction with the cytosine within the pyrimidine strand, and that at the terminal position also showed reactivity to adenine. 55) Thus we prepared two sequences of oligomers, one sequence had 2 at the internal position to be reacted with cytosine, and the other one had 2 at the external position with the adenine external to the triplex. In these experiments, 2Ј-O-methoxy (2Ј-OMe) and deoxy sugars were used to construct reactive TFOs. The use of the 2Ј-OMe sugar was expected to enhance pyrimidine triplex stability. 56, 57) These reactive TFOs showed reactivity to target model duplex (19 mer) with 25-40% yield as evaluated by gel shift assay. There was no detectable difference in the reactivity between 2Ј-OMe-TFOs and deoxy-TFOs. The extent of the reaction of each TFO to the target sequence in the mutation reporter plasmid was also determined in a restriction enzyme protection assay. The results demonstrated equivalent protection with all the TFOs (about 50%). This clearly shows that all reactive TFOs have reactivity to the target duplex DNA in vitro.
In the mutagenesis experiments, we used two shuttle vectors. One was able to detect mutations at the terminal adenine, and the other one was able to detect them at the terminal adenine and internal cytosine (Fig. 5B) . These vectors contained the supF gene, an amber suppressor tyrosine tRNA gene of Escherichia coli, which serves as a mutation reporter at target sites. In our experiments, triplex formation and target modification took place in vitro, followed by introduction of the adducted plasmids into cells. The mutation frequencies of the individual preparations ranged from 0.19% to 0.35% (Table 1) .
The mutation spectra indicated that almost all mutations were at the A or C targeted by the appropriate TFO conjugate. The 2Ј-OMe-TFO designed to react with A showed exclusively A→G mutations in both plasmids (Fig. 6) . On the other hand, the mutations with the TFO designed to react with C took place only at the target C, but were of diverse types. The mechanisms of mutagenesis are not clear but these results will serve as the basis for the development of new, more reactive, and selective reagents for targeted mutagenesis. 58) 3. DISCUSSION Reactive TFOs incorporating an alkylating agent have been used to introduce mutagenesis with sequence specificity. In particular, psoralen-conjugated TFOs can induce base-specific mutations within the reporter gene in the cell. The mechanism of mutation induction by reactive TFOs is not clear but some experiments have suggested that the repair pathway in the cell might participate in this event. 36) A high frequency of targeted mutations (an average of 30%) was observed using a psoralen-conjugated TFO in xeroderma pigmentosum variant (XPV) cells, which were human repair deficient. But in most cases, the mutation frequencies are very low, in the range of 0.01-5% and are obstacles to be overcome for the application of gene repair. A number of chemical modifications of TFOs such as to the nucleobase moiety or to the sugar backbone has been attempted to improve the binding affinity of the TFOs. 59, 60) However, there is no wellestablished assay system for the evaluation of triplex stability in vivo. Inhibition of transcription with TFOs may include factors other than triple helix formation and may not be simple reflections of triplex stability in vivo. On the other hand, photo-cross-linking should be correlated with triplex stability. Because of technical difficulties in the quantitative analysis of cross-linking within genomes, detection of mutation frequencies at the target sites might be useful for the evaluation of triple helix formation in vivo.
The TFO bearing 2-amino-6-vinylpurine can react to cytosine or adenine placed on the complementary sites and induce selective mutations at the adduct site. This new alkylating agent will have an advantage over psoralen in that the covalent modification of the bases may be accumulated during cell growth, rather than forming psoralen adducts only at the time of photo irradiation.
The frequency or efficiency of targeted mutagenesis caused by covalent bond formation is insufficient for practical applications to gene manipulation. It seemed, at least until now, to be difficult to control these complex biological events. Other than forming covalent bonds with nucleobases, there are some other chemical modifications that may cause mutations. Such modifications that alter the recognition mode of the target bases may lead directly to point mutations. If we can control such reactions in a specific manner, they would become a very useful chemical tool for gene manipulation. Studies are now ongoing along this line in our laboratory.
CONCLUSION
In this review, we focused on targeted mutagenesis of DNA based on triple helix formation. Psoralen derivatives have exhibited selective reactivity to thymine at the target site by photo activation, and point mutations caused by photo-cross linking will be useful to evaluate triplex formation in vivo. In our approach, TFOs conjugated with 2-amino-6-vinylpurine derivatives caused specific point mutations. Smart functional molecules that may alter nucleobase structures are desired for further development of reactive TFOs as a chemical tool for gene manipulation at the molecular level. Vol. 27, No. 4 
